CVSACovista Inc.

$137.84

Is the price fair?

What CVSA's price assumes

Covista Inc. trades at 21.5× earnings against 18.1× for the median Education & Training Services name, more expensive than its own group.

21.5

Trailing P/E · Education & Training Services median 18.1 · 1.19× the median: the market pays up for this one

Price / sales
2.10

Price / sales · as of 2026-Q1

Free cash flow yield
8.3%

Free cash flow yield · Education & Training Services median 10.0%

Growth the price implies
−1.1%

Growth the price implies · The price pays for −1.1% free cash flow growth a year for a decade; the business has delivered +64% a year over the last three.

Details
Price / book2026-Q1
2.94
EV / EBIT2026-Q1
11.9
EV / sales2026-Q1
2.28
Consumer Defensive median P/E115 names
21.5
Education & Training Services median P/E16 names
18.1
Free cash flow, trailing twelve months
$336M
Market capitalisation
$4.05B
3-year revenue growth
+9.7%
3-year free cash flow growth
+64%
What the market has paid for these earnings: 22 quarters of its own multiple × $6.42 of trailing earnings per share
MethodPer share
Its own P/E history, lower quartile$115.01
Its own P/E history, median$123.81
Its own P/E history, upper quartile$154.56
52-week range$89.36 – $154.45
Today$137.84

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.